Albuterol Sulfate Aerosol, Metered
Product Images NDC 0781-7296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 0781-7296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Alb05 0001 01)

FDA Label Image

Figure (Alb05 0001 02)

Figure (Alb05 0001 02)
The text represents a graph describing the percent change in FEV1 in a 12-week clinical trial using Albuterol Sulfate Inhalation Aerosol HFA. The graph shows the percentage of change in FEV1 over time (in hours) with different values ranging from 30 to 0. The names of the product and placebo are also mentioned in the graph.*
FDA Label Image

Figure A (Alb05 0001 03)

Figure A (Alb05 0001 03)
This appears to be a diagram or image of a medication inhaler that includes various parts and labels, such as a "dose indicator," "canister press," "actuator," "mouthpiece," and "cap." The diagram includes both a side view and a top view. The purpose of the inhaler is not specified in the text provided.*
FDA Label Image

Figure B (Alb05 0001 04)

FDA Label Image

Figure C (Alb05 0001 05)

FDA Label Image

Figure D (Alb05 0001 06)

FDA Label Image

Figure E (Alb05 0001 07)

FDA Label Image

Figure E (Alb05 0001 08)

FDA Label Image

Figure F (Alb05 0001 09)

FDA Label Image

Principal Display Panel – Canister (Alb05 0001 10)

Principal Display Panel – Canister (Alb05 0001 10)
This is a warning and usage instructions for Albuterol Sulfate Inhalation Aerosol HFA, administered through a mouthpiece to treat breathing problems. It contains 90mg Albuterol Sulfate and is stored between 15°C to 25°C. The inhaler should be shaken well before use. The package insert should be consulted for full prescribing information. This product is available only by prescription.*
FDA Label Image

Principal Display Panel – Carton (Alb05 0001 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.